| Tabitha B. Fortt, M.d., Llc | |
|
37 Glenbrook Rd Suite #3 Stamford CT 06902-2913 | |
| (203) 674-0774 | |
| (203) 674-0766 |
| Full Name | Tabitha B. Fortt, M.d., Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 37 Glenbrook Rd, Stamford, Connecticut |
| Authorized Official Name and Position | Tabitha B Fortt (MEMBER/MANAGER) |
| Authorized Official Contact | 2036740774 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tabitha B. Fortt, M.d., Llc 37 Glenbrook Rd Suite #3 Stamford CT 06902-2913 Ph: (203) 674-0774 | Tabitha B. Fortt, M.d., Llc 37 Glenbrook Rd Suite #3 Stamford CT 06902-2913 Ph: (203) 674-0774 |
| NPI Number | 1235597741 |
|---|---|
| Provider Enumeration Date | 01/29/2016 |
| Last Update Date | 02/02/2016 |
| Medicare PECOS PAC ID | 1850681362 |
|---|---|
| Medicare Enrollment ID | O20160610001545 |
News Archive
Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
Over the years, the AIDS virus has increasingly adapted itself to humans. This is shown by the research of Youssef Gali at the Institute of Tropical Medicine.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235597741 | NPI | - | NPPES |
| 008036735 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | 037894 (Connecticut) | Primary |
| Provider Name | Tabitha B Fortt |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1427050426 PECOS PAC ID: 5890794408 Enrollment ID: I20061208000388 |
News Archive
Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
Over the years, the AIDS virus has increasingly adapted itself to humans. This is shown by the research of Youssef Gali at the Institute of Tropical Medicine.
› Verified 1 days ago
News Archive
Aileron Therapeutics and Roche announced today that they have entered into a collaboration to discover, develop and commercialise a new class of drugs called Stapled Peptide Therapeutics. As part of this agreement, Roche will work with Aileron to develop drug candidates against up to five undisclosed targets selected from Roche's key therapeutic areas, which include oncology, virology, inflammation, metabolism and CNS.
Markers such as CA9, CD31, CD34 and VEGFR1/2 in the primary tumours might serve as predictors of a good response to a sunitinib treatment in patients with metastatic clear cell renal cell carcinoma (ccRCC), according to a new study to be presented at the 28th Annual EAU Congress currently on-going in Milan.
Sunovion Pharmaceuticals Inc. today announced the nationwide availability of ZETONNA (ciclesonide) Nasal Aerosol, 74 mcg once-daily, for the treatment of allergic rhinitis (AR), also known as hay fever or nasal allergies. ZETONNA is a corticosteroid indicated for the treatment of symptoms associated with seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in adults and adolescents 12 years of age and older.
Belmont Instrument Corporation, the widely recognized provider of blood and fluid infusers, will be introducing the new version of The Belmont Rapid Infuser, the RI-2 at the American Society of Anesthesiologists Meeting this week in New Orleans, LA.
Over the years, the AIDS virus has increasingly adapted itself to humans. This is shown by the research of Youssef Gali at the Institute of Tropical Medicine.
› Verified 1 days ago
Preferred Mdcare, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 180 Turn Of River Rd, Suite 8c, Stamford, CT 06905 Phone: 203-820-7224 Fax: 203-355-9808 | |
Bruce R. Baron, M.d., Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 583 High Ridge Rd., Stamford, CT 06905 Phone: 203-329-8651 Fax: 203-968-2635 | |
The Personalized Medicine Group Of Connecticut Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2015 W Main St, Suite 100, Stamford, CT 06902 Phone: 203-617-0742 Fax: 212-918-9394 | |
Gastroenterology Consultants, P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 778 Long Ridge Rd, Suite 101, Stamford, CT 06902 Phone: 203-967-2100 Fax: 203-967-4872 | |
Gastroenterology Hepatology Associates Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 32 Strawberry Hill Ct, Stamford, CT 06902 Phone: 203-883-9437 Fax: 203-348-3445 | |
Wellness Stamford, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 75 Tresser Blvd, Stamford, CT 06901 Phone: 646-894-3881 | |
Stamford Internal Medicine, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1351 Washington Blvd, Stamford, CT 06902 Phone: 203-322-9472 Fax: 203-322-1264 |